Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

  1. You are here:  
  2. Home
  3. Conferences
  4. Engineering
  5. AI-PI Clinical Development

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
AI-PI Clinical Development

AI-PI Clinical Development

Categories

Date of beginning

Tuesday, 24 July 2018

Duration

3 days

Deadline for abstracts

-

City

Boston

Country

USA

Contact

Shima Salmasi

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Website

http://go.evvnt.com/221391-0?pid=5569

Expected participants

0

Participants

0

Memo

Optimize Your Trial Design, Biomarker Identification and Improve Patient Selection to Deliver More Effective, Value-Based & Precision Medicines to Market



Join the AI Pharma Innovation: Clinical Development Summit to discover how to harness AI to enhance trial design, improve patient selection and identify biomarkers for precision medicine.



As clinical failure rates remain unsustainable, the inaugural AI Pharma Innovation: Clinical Development Summit is committed to help large pharma, biotech and artificial intelligence innovators overcome key strategic and technical challenges of integrating the right AI solution and applying it specifically to maximize and accelerate clinical development.



http://ai-clinicaldevelopment.com/



Price

Conference + 2 Workshops Earlybird (Book by 25/05/18): USD 3297.0

Conference + 1 Workshop Earlybird (Book by 25/05/18): USD 2798.0

Conference Earlybird (Book by 25/05/18): USD 2299.0

Conference (Standard rate): USD 2799.0



Speakers: Raj Bandaru (Sanofi), Alex Zhavoronkov (InSilico Medicine), Haoda Fu (Eli Lilly), Gregory V. Goldmacher (Merck), Arun Asaithambi (Lantern Pharma), Shanrong Zhao (Pfizer), Edward Bowen (GSK), Ray Liu (Takeda), Leonardo Rodrigues (Berg)